STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways ...

A 5-year-old boy from Center City has faced rare odds since birth and now this warrior is in a real life race to rewrite his story.

UniQure said it has aligned with the FDA on components of a statistical analysis plan for a registrational trial of AMT-130.

Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.

In comments posted in response to the Trump administration’s pharma tariff investigation, companies and industry groups ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

Mice lived 30% longer with a cancer drug combo that also slowed aging, reduced disease, and rewired gene activity.

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...

Preliminary data from ongoing Phase 1/2 trials show BEAM-302 is well tolerated and achieves dose-dependent, durable ...

Cardiovascular disease and kidney disease are two of the most urgent issues in global public health. In the United States ...